New York, NY – A few weeks ago, Waltham, Massachusetts-based healthcare research provider Decision Resources, Inc. scooped up six year old Exton, Pennsylvania-based BioTrends Research Group. BioTrends is a provider of syndicated and custom market research in the specialty pharmaceuticals industry. Terms of the deal were undisclosed.
Even though BioTrends is a small company with a mere seven employees and revenue of slightly more than $2.0 mln in 2008, the firm is considered to be an expert in the drugs used for kidney disease. BioTrends also covers the dermatology, rheumatology, gastroenterology, and immunology/infectious disease markets. BioTrend’s expertise in these segments will help Decision Resources to gain greater traction in the biopharma space.
Decision Resources, Inc. is made up of a group of companies providing data, analytics, and research on the global healthcare industry for professionals in the pharmaceutical, biotech, medical device, financial services, and managed care industries. While Decision Resources has experienced considerable organic growth in recent years, a great deal of the firm’s growth has come from acquisitions. Besides the BioTrend acquisition, Decision Resources has acquired the following companies in the past few years, including:
- Manhattan Research – June 2008
- Fingertip Formulary – March 2008
- Arlington Medical Resources – December 2007
- Wood MacKenzie’s Life Sciences Business – December 2007
- Millennium Research – February 2006
As mentioned previously, Decision Resources primarily serves various segments of the healthcare industry. However, in recent years the firm has tried to expand its presence into the financial services industry, including with sell-side analysts and buy-side investors. To accomplish this Decision Resources joined Merrill Lynch’s Open Minds platform in April 2008 to market alternative research to their institutional clients. The limited success of this endeavor led Decision Resources to join Gerson Lehrman Group’s Council Partners Program in July 2009. The jury is still out on whether this partnership will be able to help Decision Resources build considerable traction with the buy-side.
See the complete text of the Press Release below for details of Decision Resources, Inc.’s acquisition of BioTrends Research Group.
Decision Resources, Inc. Acquires Biotrends
Acquisition Adds Significant Specialized Expertise to Decision Resources, Inc.’s Biopharma Offerings
January 19, 2010—Waltham, Mass. and Exton, Penn.—Decision Resources, Inc., one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets. The acquisition of Exton, Penn.-based BioTrends by Waltham, Mass.-based Decision Resources, Inc. will result in a significant expansion of Decision Resources, Inc.’s Portfolio Planning segment of the Biopharma business unit.
Jason LaBonte, Ph.D., newly appointed Chief Operating Officer, Biopharma Portfolio Planning and Optimization said, “This important acquisition expands the breadth of our disease coverage. BioTrends’ deep clinical intimacy with specialized pharmaceutical markets and primary research-focused model enhances our high-value offerings to the biopharma industry.”
BioTrends is particularly well-known in the nephrology market, offering unique insights on drugs in that market. They also cover dermatology, gastroenterology, immunology/infectious disease and rheumatology markets and, as the newest company in the Decision Resources, Inc. portfolio, plan to expand their coverage of diseases.
“We are excited to begin our next wave of growth as a Decision Resources, Inc. company,” said Jennifer Robinson, president of BioTrends. “We bring to the table an emphasis on quality and a level of detail in our syndicated research that is second-to-none.”
BioTrends will remain headquartered in Exton, Penn.
About BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For more information, please visit www.Bio-Trends.com.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed, knowledgeable decisions. With over 450 employees worldwide, analysts at Decision Resources, Inc. companies provide the pharmaceutical, biotech, medical device, financial services and managed care industries with the analytics they need to compete and thrive in an increasingly competitive marketplace. Through both organic growth and an aggressive acquisition strategy, Decision Resources, Inc. has become the premier provider of healthcare analysis and data in the world. Visit Decision Resources, Inc. at www.DecisionResourcesInc.com.
For more information, contact:
Decision Resources, Inc.